156 related articles for article (PubMed ID: 7599047)
1. Expression of the BCL-2 protein in normal and dysplastic bronchial epithelium and in lung carcinomas.
Walker C; Robertson L; Myskow M; Dixon G
Br J Cancer; 1995 Jul; 72(1):164-9. PubMed ID: 7599047
[TBL] [Abstract][Full Text] [Related]
2. p53 expression in normal and dysplastic bronchial epithelium and in lung carcinomas.
Walker C; Robertson LJ; Myskow MW; Pendleton N; Dixon GR
Br J Cancer; 1994 Aug; 70(2):297-303. PubMed ID: 7914423
[TBL] [Abstract][Full Text] [Related]
3. Apoptotic activity is increased in parallel with the metaplasia-dysplasia-carcinoma sequence of the bronchial epithelium.
Törmänen U; Nuorva K; Soini Y; Pääkkö P
Br J Cancer; 1999 Feb; 79(5-6):996-1002. PubMed ID: 10070903
[TBL] [Abstract][Full Text] [Related]
4. Concurrent p53 expression in bronchial dysplasias and squamous cell lung carcinomas.
Nuorva K; Soini Y; Kamel D; Autio-Harmainen H; Risteli L; Risteli J; Vähäkangas K; Pääkkö P
Am J Pathol; 1993 Mar; 142(3):725-32. PubMed ID: 8456936
[TBL] [Abstract][Full Text] [Related]
5. Expression of Bcl-2, Bax, and p53 proteins in carcinogenesis of squamous cell lung cancer.
Chen Y; Sato M; Fujimura S; Endo C; Sakurada A; Aikawa H; Takahashi H; Tanita T; Kondo T; Saito Y; Sagawa M
Anticancer Res; 1999; 19(2B):1351-6. PubMed ID: 10365105
[TBL] [Abstract][Full Text] [Related]
6. P53 immunohistochemistry can identify bronchial dysplastic lesions proceeding to lung cancer: a prospective study.
Ponticiello A; Barra E; Giani U; Bocchino M; Sanduzzi A
Eur Respir J; 2000 Mar; 15(3):547-52. PubMed ID: 10759451
[TBL] [Abstract][Full Text] [Related]
7. The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model.
Bronner MP; Culin C; Reed JC; Furth EE
Am J Pathol; 1995 Jan; 146(1):20-6. PubMed ID: 7856728
[TBL] [Abstract][Full Text] [Related]
8. Value of immunohistochemical markers in preinvasive bronchial lesions in risk assessment of lung cancer.
Jeanmart M; Lantuejoul S; Fievet F; Moro D; Sturm N; Brambilla C; Brambilla E
Clin Cancer Res; 2003 Jun; 9(6):2195-203. PubMed ID: 12796386
[TBL] [Abstract][Full Text] [Related]
9. p53 and Bcl-2 expression in pneumoconiosis-related pre-cancerous lesions and lung cancers: frequent and preferential p53 expression in pneumoconiotic bronchiolar dysplasias.
Katabami M; Dosaka-Akita H; Honma K; Kimura K; Fujino M; Uchida Y; Mikami H; Ohsaki Y; Kawakami Y; Kikuchi K
Int J Cancer; 1998 Feb; 75(4):504-11. PubMed ID: 9466648
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical evidence of aberrant bcl-2 protein expression in gastric epithelial dysplasia.
Lauwers GY; Scott GV; Hendricks J
Cancer; 1994 Jun; 73(12):2900-4. PubMed ID: 8199986
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemically stained markers (p53, PCNA, bcl-2) in dysplastic lesions of the larynx.
Krecicki T; Jeleń M; Zalesska-Krecicka M; Szkudlarek T; Szajowski K
Cancer Lett; 1999 Aug; 143(1):23-8. PubMed ID: 10465333
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of bcl2, p53, mdm2 and p21/waf1 proteins in small-cell lung carcinomas.
Stefanaki K; Rontogiannis D; Vamvouka C; Bolioti S; Chaniotis V; Sotsiou F; Vlychou M; Delidis G; Kakolyris S; Georgoulias V; Kanavaros P
Anticancer Res; 1998; 18(2A):1167-73. PubMed ID: 9615783
[TBL] [Abstract][Full Text] [Related]
13. Expression of markers of differentiation in normal bronchial epithelium and bronchial dysplasia.
Pendleton N; Dixon GR; Green JA; Myskow MW
J Pathol; 1996 Feb; 178(2):146-50. PubMed ID: 8683380
[TBL] [Abstract][Full Text] [Related]
14. P53 in squamous metaplasia: a marker for risk of respiratory tract carcinoma.
Boers JE; ten Velde GP; Thunnissen FB
Am J Respir Crit Care Med; 1996 Jan; 153(1):411-6. PubMed ID: 8542151
[TBL] [Abstract][Full Text] [Related]
15. Human non-small cell lung cancer: p53 protein accumulation is an early event and persists during metastatic progression.
Fontanini G; Vignati S; Bigini D; Merlo GR; Ribecchini A; Angeletti CA; Basolo F; Pingitore R; Bevilacqua G
J Pathol; 1994 Sep; 174(1):23-31. PubMed ID: 7965400
[TBL] [Abstract][Full Text] [Related]
16. Clinical importance of p53 protein in gall bladder carcinoma and its precursor lesions.
Wee A; Teh M; Raju GC
J Clin Pathol; 1994 May; 47(5):453-6. PubMed ID: 8027399
[TBL] [Abstract][Full Text] [Related]
17. Topographical immunohistochemical expression of bcl-2 protein in human liver lesions.
Skopelitou A; Hadjiyannakis M; Alexopoulou V; Krikoni O; Kamina S; Agnantis N
Anticancer Res; 1996; 16(2):975-8. PubMed ID: 8687162
[TBL] [Abstract][Full Text] [Related]
18. Expression of hyaluronan in normal and dysplastic bronchial epithelium and in squamous cell carcinoma of the lung.
Pirinen RT; Tammi RH; Tammi MI; Pääkkö PK; Parkkinen JJ; Agren UM; Johansson RT; Viren MM; Törmänen U; Soini YM; Kosma VM
Int J Cancer; 1998 Jun; 79(3):251-5. PubMed ID: 9645346
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of bcl2, p53, mdm2 and p21/waf1 proteins in small-cell lung carcinomas.
Stefanaki K; Rontogiannis D; Vamvouka C; Bolioti S; Chaniotis V; Sotsiou F; Vlychou M; Delidis G; Kakolyris S; Georgoulias V; Kanavaros P
Anticancer Res; 1998; 18(3A):1689-95. PubMed ID: 9673391
[TBL] [Abstract][Full Text] [Related]
20. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis.
Sinicrope FA; Ruan SB; Cleary KR; Stephens LC; Lee JJ; Levin B
Cancer Res; 1995 Jan; 55(2):237-41. PubMed ID: 7812951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
